Skip to Main Content

Happy new year and welcome back from the holidays. It’s going to be an exciting year, but let’s take it one week at a time. Here’s what we’re looking for this week:

The (possible) conclusion of a biotech saga

Biotech giant Alexion Pharmaceuticals is in the throes of an internal investigation that saw the abrupt resignations of its CEO and head of finance in December. The issue, which relates to how Alexion marketed its biggest drug, the rare disease treatment Soliris, led the company to delay filing its financial results for the third quarter, further stoking speculation that something particularly bad is afoot. Alexion, based in New Haven, Conn., is widely expected to finally file those quarterly numbers this week, which should illuminate just what’s going on at the multibillion-dollar drug maker.


Obama goes on defense

President Barack Obama is rounding up congressional Democrats on Wednesday to strategize about how they might fend off Republican attempts to dismantle the Affordable Care Act, according to Politico. GOP lawmakers, emboldened by the victory of President-elect Donald Trump, have made a repeal of the law a top priority in the coming congressional session.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!